IR Reports
IR Release
| No | TITLE | FILE | DATE | COUNT |
|---|---|---|---|---|
| 98 | Q1 2022 IR release (Reviewed by External Auditor) |
|
2022.05.13 | 73 |
| 97 | Q1 2022 IR release |
|
2022.04.28 | 257 |
| 96 | Q4 2021 IR release (Reviewed by External Auditor) |
|
2022.03.15 | 171 |
| 95 | Notice of the Investment in Bukwang Pharmaceutical |
|
2022.02.22 | 38 |
| 94 | Q4 2021 IR release |
|
2022.02.08 | 615 |
| 93 | Notice of the ECH/CA Investment |
|
2021.12.01 | 2090 |
| 92 | Q3 2021 IR release (Reviewed by External Auditor) |
|
2021.11.11 | 296 |
| 91 | Q3 2021 IR release |
|
2021.10.27 | 1687 |
| 90 | Q2 2021 IR release (Reviewed by External Auditor) |
|
2021.08.11 | 162 |
| 89 | Q2 2021 IR release |
|
2021.07.28 | 990 |
You may need to install Acrobat Reader to view PDF files
